EDN1 and NF-kappa-B essential modulator measurement: After three months, they found that participants treated with the antimalarial exhibited a significant reduction in the NEMO score, microhemorrhages, microthrombosis, giant capillary score, and levels of E-selectin, VCAM, and endothelin-1 [20].